American International Group, Inc. Eiger Bio Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.89 - $2.52 $356 - $1,008	400 Added 2.03%	20,118 $18,000
Q4 2022 Feb 10, 2023	SELL	$1.02 - $7.48 $73 - $538	-72 Reduced 0.36%	19,718 $23,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $3,702 - $5,921	613 Added 3.2%	19,790 $149,000
Q2 2022 Aug 12, 2022	BUY	$4.99 - $8.96 $16,382 - $29,415	3,283 Added 20.66%	19,177 $121,000
Q1 2022 May 13, 2022	SELL	$3.84 - $9.74 $4,293 - $10,889	-1,118 Reduced 6.57%	15,894 $132,000
Q4 2021 Feb 11, 2022	SELL	$5.12 - $8.19 $2,611 - $4,176	-510 Reduced 2.91%	17,012 $88,000
Q3 2021 Nov 12, 2021	SELL	$6.68 - $9.1 $2,785 - $3,794	-417 Reduced 2.32%	17,522 $117,000
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.23 $860 - $1,015	110 Added 0.62%	17,939 $153,000
Q1 2021 May 07, 2021	BUY	$8.44 - $12.66 $405 - $607	48 Added 0.27%	17,829 $158,000
Q4 2020 Feb 12, 2021	BUY	$7.98 - $12.29 $10,677 - $16,444	1,338 Added 8.14%	17,781 $219,000
Q3 2020 Nov 04, 2020	BUY	$7.96 - $12.42 $16,190 - $25,262	2,034 Added 14.12%	16,443 $134,000
Q2 2020 Aug 12, 2020	BUY	$5.4 - $13.37 $2,872 - $7,112	532 Added 3.83%	14,409 $138,000
Q1 2020 May 04, 2020	SELL	$4.91 - $14.7 $3,932 - $11,774	-801 Reduced 5.46%	13,877 $94,000
Q4 2019 Feb 05, 2020	SELL	$9.77 - $15.66 $1,211 - $1,941	-124 Reduced 0.84%	14,678 $219,000
Q3 2019 Nov 08, 2019	SELL	$9.59 - $12.0 $987 - $1,236	-103 Reduced 0.69%	14,802 $152,000
Q2 2019 Aug 13, 2019	BUY	$9.54 - $14.96 $142,193 - $222,978	14,905 New	14,905 $158,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.